心房颤动与RAS抑制药物一类非抗心律失常药物的抗心律失常作用
摘要
心房颤动（atrialfibrillation，Af）在人群中的患病率正在不断增高，将成为新世纪心血管疾病中的一大新流行疾病，尽管有关Af的基础、临床的研究近年来都有很大进步，但迄今为止在Af的有效治疗上仍存在着很多问题，尤其是如何在高危人群中采取措施预防它的发生可谓基本空白，纵然，近年来不断有高血压、心衰等大型临床试验或研究的发表，但很少把Af的发生列入为预设终点进行观察。
出处
《老年医学与保健》
CAS
2009年第6期323-325,共3页
Geriatrics & Health Care
参考文献12
-
1Pedersen OD, Bagger H, Kober L, et al. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in Patients with left ventricular dysfunction. Circulation, 1999,100: 376-380.
-
2Vermes E, TardifJC, Bourassa MG, et al. Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials. Circulation, 2003,107: 2926-2931.
-
3Madrid AH, Bueno MG, Rebollo JM, et al. Use of irbesartan to maintain sinus rhyhm in patients with long-lasting Persistent atrialfibrillation. Circulation, 2002,106: 331-336.
-
4Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet, 2002,359: 995-1003.
-
5Wachtell K, Lehto M, Gerdts E, et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol, 2005,45: 712-719.
-
6Granger CB, McMurray J, YusufS, et al. Effects ofcandesartan in patients with chromc healt failure and reduced left ventricular systolic function intolerant to angioten- sin-converting-enzyme inhibitors: the CHARM-Alternative Trial. Lancet, 2003,362: 772-776.
-
7Val-HeFT. Post-hoc analysis suggests valsartan reduces new AF m patients with heart failure. Presentation #2457; August 30 to September3, 2003; Vienna, Austria.
-
8Healey JS, Barancuk A, Crystal E, et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. J Am Coll Cardial, 2005,45: 1832-1839.
-
9Nakashima H, Kumargai K, Urata H, et al. Angiotensin II antagonist prevents electrical remodeling in artrial fibrillation. Circulation, 2000,101: 2612-2617.
-
10Milliez P, DeAngelis N, R-Martin C, et al. Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction. Eur Heart J, 2005,26: 2193-2199.
-
1戚文航.心房颤动的预防——一类非抗心律失常药物的抗心律失常作用[J].继续医学教育,2006,20(1):59-61.
-
2周小良,吴立萍.肾素-血管紧张素系统抑制药物对心房颤动患者心房电重构的影响[J].中国基层医药,2013,20(6):939-941. 被引量：4
-
3李凌汉,麦培根,陈宝红.雷公藤多甙联合免疫抑制剂治疗类风湿关节炎疗效及对炎性因子的影响[J].现代中西医结合杂志,2017,26(10):1088-1090. 被引量：40
-
4范勇,许心纯,张银环.非抗心律失常药物治疗快速心律失常的近况[J].医药导报,1992,11(5):2-4.
-
5凌建胜,徐瑛.非抗心律失常药物治疗心律失常[J].临床荟萃,1995,10(6):268-270. 被引量：4
-
6张耀民.缬沙坦治疗阵发性房颤疗效观察[J].中国实用医药,2009,4(25):132-133.
-
7张远政,赵崇瑜.非抗心律失常药物治疗阵发性室上性心动过速[J].临床荟萃,1997,12(14):628-630.
-
8陆军.非抗心律失常药物治疗心律失常[J].中原医刊,1993,20(6):23-24.
-
9王跃钢.非抗心律失常药物治疗心律失常的临床应用[J].临床医学,1992,12(2):74-75. 被引量：1
-
10杨忠信,侯应龙.非抗心律失常药物在抗心律失常中的应用[J].陕西医学杂志,1995,24(3):169-171.
